Treatment of Lancefield group B streptococcal infections.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008826:Microbial Sensitivity Tests; D013290:Streptococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013292:Streptococcus agalactiae / Q000187:drug effects
D000900:Anti-Bacterial Agents